COVID-19Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China
Graphical abstract
Key words
Hematologic indices
immunologic responses
COVID-19
severity
outcome
Abbreviations used
COVID-19
Coronavirus disease 2019
CRP
C-reactive protein
HR
Hazard ratio
MERS
Middle East respiratory syndrome
NLR
Neutrophils-to-lymphocytes ratio
PCT
Procalcitonin
PLR
Platelets-to-lymphocytes ratio
SAA
Amyloid A protein
SARS
Severe acute respiratory syndrome
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Cited by (0)
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally as co-first authors.
© 2020 American Academy of Allergy, Asthma & Immunology